AbbVie announced that its research drug ABBV-295 showed a weight loss effect of up to 9.8% in phase 1 clinical trials, showing “meaningful weight loss.”

Zhitongcaijing · 2d ago
AbbVie announced that its research drug ABBV-295 showed a weight loss effect of up to 9.8% in phase 1 clinical trials, showing “meaningful weight loss.”